Eperison (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "Eperison" in German language version.

refsWebsite

Global rank German rank

9nih.gov

4^th place

7^th place

4doi.org

2^nd place

3^rd place

1worldcat.org

5^th place

141^st place

1pmda.go.jp

6,690^th place

low place

doi.org (Global: 2^nd place; German: 3^rd place)

Kocsis P, Farkas S, Fodor L, et al.: Tolperisone-type drugs inhibit spinal reflexes via blockade of voltage-gated sodium and calcium channels. In: J Pharmacol Exp Ther. 315. Jahrgang, Nr. 3, Dezember 2005, S. 1237–46, doi:10.1124/jpet.105.089805, PMID 16126840.
Farkas S: Silperisone: a centrally acting muscle relaxant. In: CNS Drug Rev. 12. Jahrgang, Nr. 3-4, 2006, S. 218–35, doi:10.1111/j.1527-3458.2006.00218.x, PMID 17227288.
Bresolin N, Zucca C, Pecori A: Efficacy and tolerability of eperisone and baclofen in spastic palsy: a double-blind randomized trial. In: Adv Ther. 26. Jahrgang, Nr. 5, Mai 2009, S. 563–73, doi:10.1007/s12325-009-0031-8, PMID 19458926.
Sartini S, Guerra L: Open experience with a new myorelaxant agent for low back pain. In: Adv Ther. 25. Jahrgang, Nr. 10, Oktober 2008, S. 1010–8, doi:10.1007/s12325-008-0108-9, PMID 18836866.

nih.gov (Global: 4^th place; German: 7^th place)

ncbi.nlm.nih.gov

Ono H, Fukuda H, Kudo Y: Mechanisms of depressant action of muscle relaxants on spinal reflexes: participation of membrane stabilizing action. In: J Pharmacobio-dyn. 7. Jahrgang, Nr. 3, März 1984, S. 171–6, PMID 6747808.
Kocsis P, Farkas S, Fodor L, et al.: Tolperisone-type drugs inhibit spinal reflexes via blockade of voltage-gated sodium and calcium channels. In: J Pharmacol Exp Ther. 315. Jahrgang, Nr. 3, Dezember 2005, S. 1237–46, doi:10.1124/jpet.105.089805, PMID 16126840.
Farkas S: Silperisone: a centrally acting muscle relaxant. In: CNS Drug Rev. 12. Jahrgang, Nr. 3-4, 2006, S. 218–35, doi:10.1111/j.1527-3458.2006.00218.x, PMID 17227288.
Bresolin N, Zucca C, Pecori A: Efficacy and tolerability of eperisone and baclofen in spastic palsy: a double-blind randomized trial. In: Adv Ther. 26. Jahrgang, Nr. 5, Mai 2009, S. 563–73, doi:10.1007/s12325-009-0031-8, PMID 19458926.
Cabitza P, Randelli P: Efficacy and safety of eperisone in patients with low back pain: a double blind randomized study. In: Eur Rev Med Pharmacol Sci. 12. Jahrgang, Nr. 4, 2008, S. 229–35, PMID 18727454.
Bose K: The efficacy and safety of eperisone in patients with cervical spondylosis: results of a randomized, double-blind, placebo-controlled trial. In: Methods Find Exp Clin Pharmacol. 21. Jahrgang, Nr. 3, April 1999, S. 209–13, PMID 10389124.
Sartini S, Guerra L: Open experience with a new myorelaxant agent for low back pain. In: Adv Ther. 25. Jahrgang, Nr. 10, Oktober 2008, S. 1010–8, doi:10.1007/s12325-008-0108-9, PMID 18836866.

chem.nlm.nih.gov

Eintrag zu Eperisone hydrochloride in der ChemIDplus-Datenbank der United States National Library of Medicine (NLM) (Seite nicht mehr abrufbar)

pubchem.ncbi.nlm.nih.gov

Eintrag zu Eperisone hydrochloride in der ChemIDplus-Datenbank der United States National Library of Medicine (NLM) (Seite nicht mehr abrufbar)

pmda.go.jp (Global: 6,690^th place; German: low place)

Society of Japanese Pharmacopoeia (Hrsg.): The japanese pharmacopoeia: JP XV: English version. 15. Auflage. Yakuji Nippo, Tokyo 2006, OCLC 474705025, S. 618 (Monographien D bis K [PDF]).

worldcat.org (Global: 5^th place; German: 141^st place)

Society of Japanese Pharmacopoeia (Hrsg.): The japanese pharmacopoeia: JP XV: English version. 15. Auflage. Yakuji Nippo, Tokyo 2006, OCLC 474705025, S. 618 (Monographien D bis K [PDF]).

Eperison (German Wikipedia)

doi.org (Global: 2nd place; German: 3rd place)

nih.gov (Global: 4th place; German: 7th place)